Impel Pharmaceuticals to Participate in Upcoming Investor Conferences in March
SEATTLE, March 03, 2023 (GLOBE NEWSWIRE) — Impel Pharmaceuticals Inc. (NASDAQ:IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, today announced that the Company will participate in two upcoming investor conferences in March:
Related news for (IMPL)
- Impel Pharmaceuticals Announces Filing of Voluntary Chapter 11 Cases and Signing of “Stalking Horse” Agreement to Facilitate Sale
- US Stocks Lower; Dow Falls Over 50 Points
- 12 Health Care Stocks Moving In Monday’s Pre-Market Session
- Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023
- Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023